On Tuesday, Corvus Pharmaceuticals Inc (NASDAQ: CRVS) was 165.96% up from the session before settling in for the closing price of $8.05. A 52-week range for CRVS has been $2.54 – $9.60.
A company in the Healthcare sector has jumped its sales by 8.47% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 85.33%. With a float of $57.33 million, this company’s outstanding shares have now reached $74.68 million.
Corvus Pharmaceuticals Inc (CRVS) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Corvus Pharmaceuticals Inc stocks. The insider ownership of Corvus Pharmaceuticals Inc is 23.24%, while institutional ownership is 37.81%. The most recent insider transaction that took place on Jun 27 ’25, was worth 4,891,894. In this transaction Director of this company sold 1,176,332 shares at a rate of $4.16, taking the stock ownership to the 7,165,006 shares. Before that another transaction happened on Jun 27 ’25, when Company’s Director sold 1,176,332 for $4.16, making the entire transaction worth $4,891,894. This insider now owns 7,165,006 shares in total.
Corvus Pharmaceuticals Inc (CRVS) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.14 earnings per share (EPS) during the time that was less than consensus figure (set at -0.12) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 85.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 16.75% during the next five years compared to 8.47% growth over the previous five years of trading.
Corvus Pharmaceuticals Inc (NASDAQ: CRVS) Trading Performance Indicators
You can see what Corvus Pharmaceuticals Inc (CRVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.29.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.53, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.57 in one year’s time.
